Company Filing History:
Years Active: 2013
Title: The Innovations of Sergei Spiridonov
Introduction
Sergei Spiridonov is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid sequences. His work has implications for gene identification and analysis, showcasing the intersection of molecular biology and innovative research.
Latest Patents
Sergei holds a patent that relates to nucleic acid sequences encoding a GroEL protein. This invention encompasses nucleic acid molecules found in non-coding regions, as well as those that encode proteins, fragments of proteins, tRNAs, fragments of tRNAs, rRNAs, and fragments of rRNAs. Additionally, the patent includes proteins and fragments of proteins encoded by these sequences, along with antibodies capable of binding to these proteins. The invention also outlines methods for utilizing these nucleic acid molecules and proteins for various applications, including gene identification and analysis.
Career Highlights
Sergei is currently associated with Monsanto Technology LLC, where he continues to advance his research and innovations. His work at Monsanto has allowed him to explore the practical applications of his inventions in agricultural biotechnology and related fields.
Collaborations
Throughout his career, Sergei has collaborated with esteemed colleagues, including David Richard Corbin and Barry S Goldman. These collaborations have enriched his research and contributed to the development of innovative solutions in biotechnology.
Conclusion
Sergei Spiridonov's contributions to the field of biotechnology through his patent and work at Monsanto Technology LLC highlight the importance of innovation in scientific research. His advancements in nucleic acid sequences pave the way for future discoveries and applications in gene analysis and biotechnology.